[{"Assets_0_Q2_USD":"3154300000.0","CIK":"1596783","CommonStockSharesIssued_0_Q2_shares":"124770928.0","CommonStockSharesOutstanding_0_Q2_shares":"124770928.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.14","EarningsPerShareBasic_2_Q2_USD":"0.18","EarningsPerShareDiluted_1_Q2_USD":"0.14","EarningsPerShareDiluted_2_Q2_USD":"0.17","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"17076283108.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"96000000.0","NetIncomeLoss_1_Q2_USD":"17400000.0","NetIncomeLoss_2_Q2_USD":"22000000.0","OfficialName":"Catalent Inc. Common Stock","ProfitLoss_1_Q2_USD":"17400000.0","ProfitLoss_2_Q2_USD":"22000000.0","RevenuesConverted_1_Q2_USD":"483700000.0","RevenuesConverted_2_Q2_USD":"925900000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"588000000.0","StockholdersEquity_0_Q2_USD":"588000000.0","Ticker":"CTLT","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"126414644.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"126340803.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"124889681.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"124870327.0","filed":"20170206","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"CATALENT, INC.","period":"20161231","qtrs":"0","uom":"USD"}]